Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Nektar Therapeutics
NKTR
$2.39B
| $277M | 0.15% |
302,400
-23,998
| -7% | -$20.5M |
|
177
Carter's
CRI
$1.43B
| $276M | 0.15% |
2,803,398
-60,852
| -2% | -$6.43M |
|
178
Cognex
CGNX
$10.3B
| $275M | 0.15% |
4,931,458
+134,103
| +3% | +$6.88M |
|
179
Morgan Stanley
MS
$337B
| $274M | 0.15% |
5,884,475
-237,533
| -4% | -$11.6M |
|
180
Vulcan Materials
VMC
$36.3B
| $267M | 0.14% |
2,399,201
-50,555
| -2% | -$5.86M |
|
|
181
Broadcom
AVGO
$1.82T
| $265M | 0.14% |
10,759,370
-14,313,760
| -57% | -$321M |
|
182
Ametek
AME
$55.5B
| $264M | 0.14% |
3,330,764
-147,962
| -4% | -$11.3M |
|
|
SHPG
183
DELISTED
Shire pic
SHPG
| $263M | 0.14% |
1,448,564
-251,849
| -15% | -$43.6M |
|
|
ZEN
184
DELISTED
ZENDESK INC
ZEN
| $261M | 0.14% |
3,678,304
+118,127
| +3% | +$7.54M |
|
185
Becton Dickinson
BDX
$43.1B
| $259M | 0.14% |
1,019,053
-48,323
| -5% | -$11.9M |
|
186
Automatic Data Processing
ADP
$100B
| $259M | 0.14% |
1,721,247
+74,839
| +5% | +$10.6M |
|
187
Dolby
DLB
$4.72B
| $258M | 0.14% |
3,693,200
-108,392
| -3% | -$7.27M |
|
188
Hilton Worldwide
HLT
$74B
| $258M | 0.14% |
3,195,615
+785,204
| +33% | +$61.9M |
|
189
Caterpillar
CAT
$409B
| $255M | 0.14% |
1,673,717
-283,772
| -14% | -$40.1M |
|
|
FISV
190
Fiserv Inc
FISV
$27.2B
| $255M | 0.14% |
3,090,513
-176,839
| -5% | -$13.9M |
|
|
TSS
191
DELISTED
Total System Services, Inc.
TSS
| $252M | 0.13% |
2,554,111
-343,324
| -12% | -$32.3M |
|
192
Kroger
KR
$34.8B
| $250M | 0.13% |
8,598,134
+463,292
| +6% | +$13.8M |
|
193
Donaldson
DCI
$10.8B
| $250M | 0.13% |
4,291,225
-69,455
| -2% | -$3.49M |
|
194
Centene
CNC
$31.3B
| $248M | 0.13% |
3,420,308
+80,828
| +2% | +$5.61M |
|
195
Ligand Pharmaceuticals
LGND
$6.02B
| $247M | 0.13% |
1,442,839
-43,304
| -3% | -$6.53M |
|
196
Crown Holdings
CCK
$12.8B
| $247M | 0.13% |
5,136,465
+743,969
| +17% | +$33.1M |
|
197
T. Rowe Price
TROW
$25B
| $245M | 0.13% |
2,247,254
+449,322
| +25% | +$52M |
|
|
198
DexCom
DXCM
$27.6B
| $245M | 0.13% |
6,844,888
-10,924,604
| -61% | -$339M |
|
199
Omnicom Group
OMC
$22.7B
| $245M | 0.13% |
3,597,854
+79,759
| +2% | +$5.59M |
|
200
HealthEquity
HQY
$7.91B
| $242M | 0.13% |
2,562,148
-65,326
| -2% | -$5.63M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.